JP7575163B2 - アスリートのオーバートレーニングの予防又は処置に用いる化合物 - Google Patents

アスリートのオーバートレーニングの予防又は処置に用いる化合物 Download PDF

Info

Publication number
JP7575163B2
JP7575163B2 JP2021518512A JP2021518512A JP7575163B2 JP 7575163 B2 JP7575163 B2 JP 7575163B2 JP 2021518512 A JP2021518512 A JP 2021518512A JP 2021518512 A JP2021518512 A JP 2021518512A JP 7575163 B2 JP7575163 B2 JP 7575163B2
Authority
JP
Japan
Prior art keywords
overtraining
composition
subject
ketone
training
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021518512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022504207A (ja
JP2022504207A5 (https=
JPWO2020070506A5 (https=
Inventor
クラーク，キーラン
ヘスペル，ピーター
Original Assignee
ティーデルタス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ティーデルタス リミテッド filed Critical ティーデルタス リミテッド
Publication of JP2022504207A publication Critical patent/JP2022504207A/ja
Publication of JP2022504207A5 publication Critical patent/JP2022504207A5/ja
Publication of JPWO2020070506A5 publication Critical patent/JPWO2020070506A5/ja
Application granted granted Critical
Publication of JP7575163B2 publication Critical patent/JP7575163B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2021518512A 2018-10-04 2019-10-03 アスリートのオーバートレーニングの予防又は処置に用いる化合物 Active JP7575163B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1816196.8A GB2577723A (en) 2018-10-04 2018-10-04 Compounds for new use
GB1816196.8 2018-10-04
PCT/GB2019/052797 WO2020070506A1 (en) 2018-10-04 2019-10-03 Compounds for use in preventing or treating athlete overtraining

Publications (4)

Publication Number Publication Date
JP2022504207A JP2022504207A (ja) 2022-01-13
JP2022504207A5 JP2022504207A5 (https=) 2022-09-22
JPWO2020070506A5 JPWO2020070506A5 (https=) 2022-09-22
JP7575163B2 true JP7575163B2 (ja) 2024-10-29

Family

ID=68242730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021518512A Active JP7575163B2 (ja) 2018-10-04 2019-10-03 アスリートのオーバートレーニングの予防又は処置に用いる化合物

Country Status (9)

Country Link
US (1) US12290496B2 (https=)
EP (1) EP3860584B1 (https=)
JP (1) JP7575163B2 (https=)
KR (1) KR102868881B1 (https=)
CN (1) CN112996498B (https=)
AU (1) AU2019351925B2 (https=)
CA (1) CA3114889A1 (https=)
GB (2) GB2577723A (https=)
WO (1) WO2020070506A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202100020441A1 (it) 2021-07-30 2023-01-30 Unichem Estense S R L Miscela di un mono-estere e un di-estere, in cui detti mono-estere e di-estere sono esteri dell’acido (R)-3-idrossibutanoico con un polialcol, processo per la preparazione della miscela e relativi usi medici
CN118591523A (zh) * 2021-11-12 2024-09-03 阿萨达股份公司 多元醇衍生的化合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090253781A1 (en) 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
EP1648952B1 (en) * 2003-06-03 2018-03-07 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
SE0400355D0 (sv) 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
WO2006020137A2 (en) 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
EP1778615A4 (en) 2004-07-20 2010-01-06 Btg Int Ltd OLIGOMERE KETONE COMPOUNDS
CN100344280C (zh) * 2005-08-01 2007-10-24 清华大学 3－羟基丁酸及其衍生物的新用途
WO2008110034A1 (en) 2007-03-14 2008-09-18 Shantou University 3-hydroxy fatty acid and its derivatives for improving of learning and/or memory of subjects
EP2240017B1 (en) 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
JP5773870B2 (ja) 2008-08-21 2015-09-02 アイシス イノヴェイション リミテッド ヒドロキシ酪酸エステル及びその医学的使用
US8865641B2 (en) 2011-06-16 2014-10-21 The Feinstein Institute For Medical Research Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
GB201206192D0 (en) * 2012-04-05 2012-05-23 Tdeltas Ltd Ketone bodies and ketone body esters and for maintaining or improving muscle power output
GB2515603B (en) 2013-03-14 2015-10-14 Isis Innovation Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
CA2902603C (en) 2013-03-19 2021-03-02 University Of South Florida Compositions and methods for producing elevated and sustained ketosis
US11814664B2 (en) 2013-05-24 2023-11-14 Genomatica, Inc. Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate
GB201314127D0 (en) * 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
US20150283163A1 (en) * 2014-04-04 2015-10-08 Organic Medical Ventures, L.L.C. Muscle treatment composition and method making same
US20180008629A1 (en) 2015-01-29 2018-01-11 Yale University Compositions and Methods for Treating NLRP3 Inflammasome-Related Diseases and Disorders
EA201791982A1 (ru) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
CA3021784A1 (en) 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
GB201710229D0 (en) 2017-06-27 2017-08-09 Tdeltas Ltd Compounds for new use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HOLDWORTH, D.A., et al.，Medicine and science in sports and exercise，2017年，Vol. 49，No. 9，pp.1789-1795.
KREHER, J.B., et al.，Sports health，2012年，Vol. 4，No. 2，pp.128-138.

Also Published As

Publication number Publication date
CA3114889A1 (en) 2020-04-09
JP2022504207A (ja) 2022-01-13
KR20210079304A (ko) 2021-06-29
WO2020070506A1 (en) 2020-04-09
KR102868881B1 (ko) 2025-10-15
GB2592803B (en) 2022-11-09
GB2592803A (en) 2021-09-08
US20210338612A1 (en) 2021-11-04
CN112996498B (zh) 2024-10-29
EP3860584A1 (en) 2021-08-11
AU2019351925A1 (en) 2021-04-15
GB202105967D0 (en) 2021-06-09
CN112996498A (zh) 2021-06-18
AU2019351925B2 (en) 2024-12-05
EP3860584B1 (en) 2026-02-18
GB2577723A (en) 2020-04-08
US12290496B2 (en) 2025-05-06

Similar Documents

Publication Publication Date Title
US11219590B2 (en) Anti-aging agent and anti-aging method
JP6830359B2 (ja) 栄養組成物
JP6241956B2 (ja) 筋パワー出力を維持又は改善するためのケトン体及びケトン体エステル
EP3030231B1 (en) Ketone body and ketone body ester for reducing muscle breakdown
DK2328858T3 (en) Drink comprehensive hydroxybutyrate ester and its medical use
EP3850954A1 (en) Anti-aging agent and anti-aging method
US20150174088A1 (en) Food supplement containing alpha-keto acids for supporting diabetes therapy
CN111132674A (zh) 治疗方法
KR20240004452A (ko) 1-메틸크산틴-기반 생체활성 조성물 및 이의 사용 방법
JP7575163B2 (ja) アスリートのオーバートレーニングの予防又は処置に用いる化合物
EP2617429A1 (en) Fat oxidation or energy metabolism enhancer
JP2007000081A (ja) 脂質代謝改善用食品
JP2019043857A (ja) ＡｐｏＡ１又はＴＴＲ産生促進剤
NO20230263A1 (en) Physical performance aid
WO2025004650A1 (ja) 中高年者の疲労感を軽減するための剤及び組成物
HK40128314A (zh) Capsaicyn用作体能表现助剂
CN117979971A (zh) 基于1-甲基黄嘌呤的生物活性组合物及其使用方法
KR20210100652A (ko) 스포츠 성능 개선을 위한 망기페린-함유 생약 조성물
HK1159604B (en) Hydroxybutyrate ester and medical use thereof
HK1225965B (en) Ketone body and ketone body ester for reducing muscle breakdown
WO2002069956A2 (en) Use of carnitine for increasing testosteron

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220913

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220913

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231010

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240402

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240617

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240917

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241011

R150 Certificate of patent or registration of utility model

Ref document number: 7575163

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150